Prophylactic antibiotics in hip and knee arthroplasty

Area of Science:

• Orthopedic Surgery
• Infectious Diseases
• Hospital Epidemiology

Background:

• Parenteral antibiotics are crucial in preventing surgical site infections (SSIs) after hip and knee arthroplasty.
• A shift in methicillin-resistant Staphylococcus aureus (MRSA) infection patterns from hospital-acquired to community-acquired has been observed.
• Recent studies on MRSA carrier screening programs yield equivocal results regarding their effectiveness in reducing SSIs.

Purpose of the Study:

• To review the current landscape of prophylactic antibiotic use in hip and knee arthroplasty.
• To evaluate the efficacy of MRSA screening programs in preventing SSIs.
• To provide recommendations for antibiotic prophylaxis in light of changing MRSA epidemiology.

Main Methods:

• Literature review of studies on prophylactic antibiotics and MRSA screening in arthroplasty.
• Analysis of trends in MRSA infection acquisition.
• Synthesis of findings on the impact of screening on SSI rates.

Main Results:

• Prophylactic antibiotics have successfully lowered SSI rates in joint replacement surgeries.
• The effectiveness of MRSA carrier screening programs in reducing SSIs remains inconclusive.
• Some studies indicate a benefit, while others show no significant impact on infection rates.

Conclusions:

• Hospitals with high Staphylococcus resistance, based on antibiogram data, should consider vancomycin for prophylactic use.
• Further research is needed to clarify the role and optimal implementation of MRSA screening programs.
• Adjusting prophylactic strategies based on local resistance patterns is essential for effective SSI prevention.